Barclays’s Biomea Fusion BMEA Stock Holding History
Bought
Maintained
Sold
Other funds holding BMEA
ACM
FISPB
Barclays's BMEA Position: Q2 2026 in Review
Barclays reduced its Biomea Fusion (BMEA) stake by 97% in Q2 2026, selling an estimated $74.6K and leaving 1,593 shares worth $2.34K. The position accounts for ﹤0.01% of the portfolio, ranked #4857.
Barclays first reported a position in BMEA in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.6M in Q3 2023. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.
- Barclays held 1,593 shares of Biomea Fusion worth $2.34K as of Q2 2026.
- Barclays sold 50,013 Biomea Fusion shares in Q2 2026, an estimated $74.6K.
- Biomea Fusion made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4857 holding.
- Barclays first reported a position in Biomea Fusion in Q1 2022 and has held it in 18 quarters since.
- Barclays's Biomea Fusion position peaked at $1.6M in Q3 2023.
- 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.